Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months

Clinical Endocrinology

Volumn 51, Issue 5, 1999, Pages 611-618

  Colao, Annamaria ^a   Marzullo, Paolo ^b   Vallone, Gianfranco ^b   Giaccio, Assunta ^b   Ferone, Diego ^b   Rossi, Eugenio ^b   Scarpa, Raffaele ^b   Smaltino, Francesco ^b   Lombardi, Gaetano ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ANKLE; ARTHRALGIA; ARTHROPATHY; ARTICLE; ARTICULAR CARTILAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ECHOGRAPHY; FEMALE; HEEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; JOINT MOBILITY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHOULDER; SOFT TISSUE DISEASE; WEIGHT BEARING; WRIST;

ACROMEGALY; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE, ARTICULAR; FEMALE; GROWTH HORMONE; HEEL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JOINT DISEASES; KNEE JOINT; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PROSPECTIVE STUDIES; SHOULDER JOINT; SOMATOSTATIN; TENDONS; WRIST JOINT;

EID: 0032727434     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00851.x     Document Type: Article

References (29)

1. Al-Maskari, M., Gebbie, J. & Kendall-Taylor, P. (1996) The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly. Clinical Endocrinology, 45, 415-421.
2. Barkan, A. (1997) Acromegalic arthropathy and sleep apnea. Journal of Endocrinology, 155, S41-S44.
3. Bluestone, R., Bywaters, E., Hartog, M., Holt, P.J.L. & Hyde, S. (1971) Acromegalic arthropathy. Annals of Rheumatic Diseases, 30, 43-258.
4. Caron, P., Morange-Ramos, I., Cogne, M. & Jaquet, P. (1997) Three years follow-up of acromegalic patients treated with intramuscular slow-release lanreotide. Journal of Clinical Endocrinology and Metabolism, 82, 18-22.
5. Chrisman, O.D. (1975) The effect of growth hormone on established cartilage lesions. Clinical Orthopedics, 107, 232-238.
6. Clayton, R.N. (1997) New developments in the management of acromegaly. Should we achieve absolute biochemical cure? Journal of Endocrinology, 155, S23-S29.
7. Colao, A., Ferone, D., Lastoria, S., Marzullo, P., Cerbone, G., Di Sarno, A., Longobardi, S., Merola, B., Salvatore, M. & Lombardi, G. (1996) Prediction of efficacy of octreotide therapy in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 81, 2356-2362.
8. Colao, A., Merola, B., Ferone, D. & Lombardi, G. (1997) Acromegaly. Journal of Clinical Endocrinology and Metabolism, 84, 2777-2781.
9. Colao, A. & Lombardi, G. (1998) Growth hormone and prolactin excess. Lancet, 352, 1455-1461.
10. Colao, A., Marzullo, P., Vallone, G., Marinò, V., Annecchino, M., Ferone, D., De Brasi, D., Scarpa, R., Oriente, P. & Lombardi, G. (1998) Reversibility of joint thickening in acromegalic patients: an ultrasonography study. Journal of Clinical Endocrinology and Metabolism, 83, 2121-2125.
11. Colao, A., Marzullo, P., Ferone, D., Marinò, V., Pivonello, R., Di Somma, C., Di Sarno, A., Giaccio, A. & Lombardi, G. (1999a) Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly. Journal of Endocrinological Investigation, 22, 40-47.
12. Colao, A., Cuocolo, A., Marzullo, P., Nicolai, E., Ferone, D., Florimonte, L., Salvatore, M. & Lombardi, G. (1999b) Effects of one-year treatment with octreotide on cardiac performance in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 84, 17-23.
13. Detenbeck, L., Tressler, H., O'Duffy, J. & Randall, R.V. (1973) Peripheral joint manifestations of acromegaly. Clinical Orthopedics, 91, 119-127.
14. Dons, R.F., Rosselet, P., Pastakia, B., Doppman, J. & Gorden, P. (1988) Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study. Clinical Endocrinology, 28, 515-524.
15. Giusti, M., Gussoni, G., Cuttica, C.M., Giordano, G. & The Italian Multicenter Slow Release Lanreotide Study Group (1996) Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on a Italian multicenter study. Journal of Clinical Endocrinology and Metabolism, 81, 2089-2097.
16. Holt, P. (1981) Locomotor abnormalities in acromegaly. Clinical Rheumatic Diseases, 7, 689-709.
17. Johanson, N.A., Vigorita, V.J., Goldman, A.B. & Slavati, E.A. (1983) Acromegalic arthropathy of the hip. Clinical Orthopedics, 173, 130-139.
18. Kellgren, J.H., Ball, J. & Tutton, G.K. (1952) The articular and other limb changes in acromegaly. Quarterly Journal of Medicine, 21, 405-423.
19. Lacks, S. & Jacobs, R.P. (1986) Acromegalic arthropathy: a reversible rheumatic disease. Journal of Rheumatology, 13, 634-636.
20. Lamberts, S.W.J., Uitterlinden, P., Verschoor, L., van Dongen, K.L. & del Pozo, E. (1985) Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. New England Journal of Medicine, 313, 1576-1580.
21. Lamberts, S.W.J., van Der Lely, A.-J., de Herder, W.W. & Hofland, L.J. (1996) Octreotide. New England Journal of Medicine, 334, 246-254.
22. Layton, M.W., Fudman, E.J., Barkan, A., Braunstein, E.M. & Fox, I.H. (1988) Acromegalic arthropathy: characteristics and response to therapy. Arthritis and Rheumatism, 31, 1022-1027.
23. Manger, B. & Kalden, J. (1995) Joint and connective tissue ultrasonography - a rheumatologic bedside procedure? Arthritis and Rheumatism, 38, 736-742.
24. Marek, J., Hana, V., Krsek, M., Justova, V., Catus, F. & Thomas, F. (1994) Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide. European Journal of Endocrinology, 131, 20-26.
25. Melmed, S., Ho, K., Klibanski, A., Reichlin, S. & Thorner, M. (1995) Recent advances in pathology, diagnosis and management of acromegaly. Journal of Clinical Endocrinology and Metabolism, 80, 3395-3402.
26. Newman, C.B., Melmed, S., George, A., Torigian, D., Duhaney, M., Snyder, P., Young, W., Klibanski, A., Molitch, M.E., Gagel, R., Sheeler, L., Cook, D., Malarkey, W., Jackson, I., Vance, M.L., Barkan, A., Frohman, L. & Kleinberg, D.L. (1998) Octreotide as primary therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3034-3040.
27. Roelfsema, F., Vandulken, H. & Frolich, M. (1986) Long-term result of trans-sphenoidal pituitary microsurgery in 60 acromegalic patients. Clinical Endocrinology, 23, 555-565.
28. Sledge, C.B. (1973) Growth hormone and articular cartilage. Federation Proceedings, 32, 1503-1505.
29. Waine, H., Bennet, G.A. & Bauer, W. (1945) Joint disease associated with acromegaly. American Journal of Medical Sciences, 209, 671-678.